Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045
In a Society of Healthcare Epidemiology of American (SHEA) podcast, Dr. Megan Jeffres, PharmD, BCIDP, discusses why intravenous (IV) to oral (PO) conversion has immense potential to benefit patients by preventing unnecessary intravenous therapy associated with risks such as prolonged length of stay, line-associated infections, and excess cost and inconvenience.
Robert Page, PharmD, weighs in on the need for well-designed clinical trials to test the safety and efficacy of cannabidiol (CBD) for cardiovascular disease, based on evidence from preclinical studies showing that it has anti-inflammatory effects.
Dr. Gina Moore, PharmD, MBA, talks with Health on why this viral TikTok trend is a dangerous misuse of medication.
A new study from Molly, Huntsman, PhD, suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.
CU Pharmacy and Cancer Center researcher Dmitri Simberg, PhD, is focusing on penetrating the blood-brain barrier in glioblastoma to more effectively deliver anti-cancer therapies.